Skip to main content
. 2020 Jun 4;2(Suppl 1):1–10. doi: 10.1093/noajnl/vdaa070

Table 3.

Descriptive Statistics of Extent of Resection by Treatment Combinations Among Glioblastoma Patients Who Received Surgery, NCDB 2010–2015 (n = 39 801)

All modalities (n = 28 587) P Surgery + radiation (n = 2494) P Surgery + chemo (n = 1184) P Surgery only (n = 7536) P
Longer-term survivors (n = 3385) Routine survivors (n = 25 202) Longer-term survivors (n = 116) Routine survivors (n = 2378) Longer-term survivors (n = 96) Routine survivors (n = 1088) Longer-term survivors (n = 374) Routine survivors (n = 7162)
Extent of  resection,  n (%) <.001a .008a .624a <.001a
 Biopsy 580 (17.13) 5024 (19.93) 21 (18.10) 592 (24.89) 20 (20.83) 242 (22.24) 90 (24.06) 1917 (26.77)
 Subtotal 855 (25.26) 7982 (31.67) 28 (24.14) 759 (31.92) 25 (26.04) 323 (29.69) 70 (18.72) 2179 (30.42)
 Total 1950 (57.61) 12 196 (48.39) 67 (57.76) 1027 (43.19) 51 (53.13) 523 (48.07) 214 (57.22) 3066 (42.81)

All modalities: surgery + radiation + chemotherapy.

aChi-square test.